Status: Recruiting
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
The purpose of this registry is to evaluate the long-term safety and performance of Intervascular Vascular Grafts and Patches (Intergard Standard, Hemashield, Intergard Silver, Intergard Synergy) for bypass, repair or replacement of aortic, peripheral, or carotid arteries. This registry is intended to further define the expected product lifetime of the devices and to collect data related to usefulness of the antimicrobial coatings.
Participants needed: 1,200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: IntervascularUpdated: Jun 15, 2026Locations: 4
Eligibility criteria
Willing, and able to provide legally-effective written informed consent (as requ... [+3]
Active infection in the region of device placement at the time of implantation o...